Granzyme B Polyclonal antibody 13588-1-AP proteintech

$149.00
In stock
SKU
13588-1-AP
Catalog No.SizePrice (USD)
13588-1-AP-20UL20 μL$149.00
13588-1-AP-150UL150 μL$449.00
Catalog Number13588-1-AP
SynonymsGZMB, Cathepsin G-like 1, CCPI, CGL 1, CGL1
HostRabbit
Reactivityhuman, mouse and More (1)
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, IF-P, IF-Fro, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inHL-60 cells
Tested Applications — Positive IHC detected inhuman lymphoma tissue, mouse spleen tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF-P detected inmouse spleen tissue
Tested Applications — Positive IF-Fro detected inmouse spleen tissue
Tested Applications — Positive IF/ICC detected inJurkat cells
Recommended Dilutions — Western Blot (WB)WB : 1:500-1:2000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:50-1:500
Recommended Dilutions — Immunofluorescence (IF)-PIF-P : 1:50-1:500
Recommended Dilutions — Immunofluorescence (IF)-FROIF-FRO : 1:50-1:500
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Positive WB detected inHL-60 cells
Positive IHC detected inhuman lymphoma tissue, mouse spleen tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF-P detected inmouse spleen tissue
Positive IF-Fro detected inmouse spleen tissue
Positive IF/ICC detected inJurkat cells
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)-PIF-P : 1:50-1:500
Immunofluorescence (IF)-FROIF-FRO : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
Tested Reactivityhuman, mouse
Cited Reactivityhuman, mouse, rat
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag3883 Product name: Recombinant human GZMB protein Source: e coli. -derived, PGEX-4T Tag: GST Domain: 1-247 aa of BC030195 Sequence: MQPILLLLAFLLLPRADAGEIIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHCWGSSINVTLGAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIELCVGDPEIKKTSFKGDSGGPLVCNKVAQGIVSYGRNNGMPPRACTKVSSFVHWIKKTMKRH Predict reactive species
Full Namegranzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
Calculated Molecular Weight247 aa, 28 kDa
Observed Molecular Weight33 kDa
GenBank Accession NumberBC030195
Gene SymbolGranzyme B
Gene ID (NCBI)3002
RRIDAB_2114429
ConjugateUnconjugated
Purification MethodAntigen affinity purification
UNIPROT IDP10144
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for Granzyme B antibody 13588-1-APDownload protocol
IHC protocol for Granzyme B antibody 13588-1-APDownload protocol
WB protocol for Granzyme B antibody 13588-1-APDownload protocol
humanIHC Oncogene B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression. Authors - Youwei Lu View Article
mouseIHC Clin Transl Med c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis. Authors - Lan Zhang View Article
Ipsita (Verified Customer) (06-25-2026)Strong signal for IF in Mouse Vaginal Tissue at a dilution of 1:500 Applications: Immunofluorescence Primary Antibody Dilution: 1:500 Cell Tissue Type: Mouse vaginal column tissue
Citations96
DilutionsWB : 1:500-1:2000 IHC : 1:50-1:500 IF-P : 1:50-1:500 IF-FRO : 1:50-1:500 IF/ICC : 1:200-1:800
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

GZMB(Granzyme B) is also named as CGL1, CSPB, CTLA1, GRB and belongs to the Granzyme subfamily. This enzyme is necessary for target cell lysis in cell-mediated immune responses. The cytotoxic lymphocyte protease granzyme B (GzmB) can promote apoptosis through direct processing and activation of members of the caspase family. GzmB can also cleave the BH3-only protein, BID, to promote caspase-independent mitochondrial permeabilization (PMID:17283187). GzmB induces laminB degradation in isolated nuclei less efficiently than GzmA (PMID:11331782). This full length protein has 2 glycosylation sites and a signal peptide. Unglycosylated human granzyme B is 26 kDa and high mannose glycosylated is 32 kDa and only 32kDa or smaller forms of granzyme B are accumulated within nuclei (PMID:8626751). GzmB also forms dimers. Protocols Product Specific Protocols IF protocol for Granzyme B antibody 13588-1-AP Download protocol IHC protocol for Granzyme B antibody 13588-1-AP Download protocol WB protocol for Granzyme B antibody 13588-1-AP Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Journal: J Am Acad Dermatol | Authors: Yung-Tsu Cho | Species: human | Application: IHC
  2. In situ subcutaneously injectable thermosensitive PEG-PLGA diblock and PLGA-PEG-PLGA triblock copolymer composite as sustained delivery of bispecific anti-CD3 scFv T-cell/anti-EGFR Fab Engager (BiTEE).
    Journal: Biomaterials | Authors: Pu-Sheng Wei | Species: mouse | Application: IHC
  3. Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Journal: J Nanobiotechnology | Authors: Xingyi Wang | Species: mouse | Application: IHC
  4. Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy.
    Journal: Cancer Immunol Res | Authors: Chunlin Li | Species: mouse | Application: IHC
  5. B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression.
    Journal: Oncogene | Authors: Youwei Lu | Species: human | Application: IHC
  6. c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.
    Journal: Clin Transl Med | Authors: Lan Zhang | Species: mouse | Application: IHC
  7. Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1
    Journal: Cell Metab | Authors: Yizeng Fan
  8. Induction of Tumor Ferroptosis-Dependent Immunity via an Injectable Attractive Pickering Emulsion Gel
    Journal: Adv Mater | Authors: Xiaomeng Dai | Species: mouse | Application: IHC,IF
  9. An Immune Subtype Classification System Enables the Development of Strategies to Predict and Enhance Immunotherapy Responses in Colorectal Cancer
    Journal: Cancer Res | Authors: Dingchang Li | Species: mouse | Application: IHC,IF
  10. The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity
    Journal: Drug Resist Updat | Authors: Hao Wu | Application: IHC
  11. Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity.
    Journal: Nat Commun | Authors: Yonghua Li | Species: mouse,human | Application: IF
  12. In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy
    Journal: Nat Commun | Authors: Chunping Mao | Species: mouse
  13. Single-cell transcriptomics reveals intestinal cell heterogeneity and identifies Ep300 as a potential therapeutic target in mice with acute liver failure
    Journal: Cell Discov | Authors: Jie Yin | Species: mouse | Application: IF
  14. DMNQ induces ferroptosis and augments the efficacy of anti-PD-L1 immunotherapy in gastric cancer via the STAT3/SLC1A4 axis to mediate cysteine metabolism reprogramming.
    Journal: Redox Biol | Authors: Wenshuai Zhu | Species: mouse | Application: IF
  15. Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
    Journal: J Nanobiotechnology | Authors: Xingyi Wang | Species: mouse | Application: IHC
  16. SIRT2-mediated deacetylation activates USP22 catalytic function for PD-L1 protein stabilization and tumor immune escape.
    Journal: J Clin Invest | Authors: Na Li
  17. Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signaling
    Journal: J Clin Invest | Authors: Wenjie Wei | Species: mouse | Application: IF
  18. Mutual Exclusion Analysis Shows that DUSP9 Negatively Regulates PD-L1 Expression and Acts as a Target to Enhance Anti-PD-1 Efficacy.
    Journal: Adv Sci (Weinh) | Authors: Yuzhe Hu | Species: human, mouse | Application: WB,IHC,IF
  19. Mutual Exclusion Analysis Shows that DUSP9 Negatively Regulates PD-L1 Expression and Acts as a Target to Enhance Anti-PD-1 Efficacy.
    Journal: Adv Sci (Weinh) | Authors: Yuzhe Hu | Species: human, mouse | Application: WB,IHC,IF
  20. EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS-STING Pathway.
    Journal: Adv Sci (Weinh) | Authors: Liyun Huo | Species: human,mouse | Application: IF
  21. A Microbial Lipid-ATP Synthase Axis Fuels NK Cell Antitumor Activity.
    Journal: Adv Sci (Weinh) | Authors: Kaiyuan Yu | Species: mouse | Application: IF
  22. Glabridin-Gold(I) Complex as a Novel Immunomodulatory Agent Targeting TrxR and MAPK Pathways for Synergistic Enhancement of Antitumor Immunity
    Journal: Adv Sci (Weinh) | Authors: Zhaoran Wang
  23. Targeting KMT5C Suppresses Lung Cancer Progression and Enhances the Efficacy of Immunotherapy
    Journal: Adv Sci (Weinh) | Authors: Yunfeng Yuan | Species: mouse | Application: IHC
  24. LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling.
    Journal: Cell Rep Med | Authors: Lizhou Lin | Species: mouse | Application: WB
  25. Biomimetic cell membrane-coated glucose/oxygen-exhausting nanoreactor for remodeling tumor microenvironment in targeted hypoxic tumor therapy
    Journal: Biomaterials | Authors: Haoyu Guo | Species: human | Application: IHC
  26. In situ subcutaneously injectable thermosensitive PEG-PLGA diblock and PLGA-PEG-PLGA triblock copolymer composite as sustained delivery of bispecific anti-CD3 scFv T-cell/anti-EGFR Fab Engager (BiTEE).
    Journal: Biomaterials | Authors: Pu-Sheng Wei | Species: mouse | Application: IHC
  27. Structural characterization and antitumor activity via immune modulation of an α-glucan from Grifola frondosa.
    Journal: Carbohydr Polym | Authors: Hui-Xiang Tian | Species: mouse | Application: IHC
  28. PRMT5-Mediated Arginine Methylation of ACSL4 Attenuates Its Stability and Suppresses Ferroptosis in Renal Cancer
    Journal: Research (Wash D C) | Authors: Meng Zhang | Application: IHC
  29. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Journal: J Am Acad Dermatol | Authors: Yung-Tsu Cho | Species: human | Application: IHC
  30. Metformin sensitizes esophageal squamous cell carcinoma to Vγ9Vδ2 T cell-mediated cytotoxicity by upregulating BTN3A1 and BTN2A1.
    Journal: Cell Death Dis | Authors: Zishan Yang | Species: human | Application: IF
  31. NAD+ Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment
    Journal: Cell Death Dis | Authors: Jiacheng Shen | Application: WB
  32. The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7-H4 in lung adenocarcinoma harboring EGFR-activating mutants
    Journal: Cancer Lett | Authors: Youwei Lu | Species: mouse | Application: IHC
  33. The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Rα-armored CAR-T cells against glioblastoma
    Journal: Cancer Lett | Authors: You Zhai | Species: human | Application: IF
  34. Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer
    Journal: Cancer Lett | Authors: Han Wang | Species: human | Application: IHC
  35. DysUFMylation reprograms immunosuppressive neutrophils to potentiate anti-PD-1 therapy in hepatocellular carcinoma.
    Journal: Cancer Lett | Authors: Xukang Gao | Species: human | Application: IHC,IF
  36. Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48
    Journal: J Immunother Cancer | Authors: Jiatong Xiao | Application: IF
  37. Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
    Journal: Cell Commun Signal | Authors: Yuqi Yang | Species: mouse | Application: IF
  38. Xiao-Yao-San suppresses psychological distress-related colorectal cancer metastasis and enhances antitumor immune responses through regulating gut microbiota-bile acid axis.
    Journal: Phytomedicine | Authors: Xinxin Hou
  39. Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC
    Journal: J Pharm Anal | Authors: Feifei Li | Species: mouse,human | Application: WB
  40. Light-controlled pyroptosis via redox-responsive microneedles enhances photodynamic-epigenetic immunotherapy in breast cancer.
    Journal: Mater Today Bio | Authors: Hang Yu | Species: mouse | Application: IHC,IF
  41. Activated T-cell membrane-derived nanocargoes displaying multi-immune checkpoints for enhanced cancer immunotherapy.
    Journal: Mater Today Bio | Authors: Li Du | Species: mouse | Application: IF
  42. Cryo-trojan mesenchymal stem cells as non-living tumor-homing supercarriers for enhanced drug delivery and immune activation in prostate cancer
    Journal: Mater Today Bio | Authors: Chengran Wang | Species: mouse | Application: IF
  43. Multimodal spatial proteomic profiling in acute myeloid leukemia
    Journal: NPJ Precis Oncol | Authors: Christopher P Ly | Species: human
  44. Plant-derived CTLA-4-targeting miR152 via lipid nanoparticles potentiates doxorubicin efficacy in breast cancer immunochemotherapy.
    Journal: Sci China Life Sci | Authors: Hanyi Ye
  45. B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression.
    Journal: Oncogene | Authors: Youwei Lu | Species: human | Application: IHC
  46. Synergistic reprogramming of the tumor immune microenvironment by Senecavirus A and STING agonist.
    Journal: Oncogene | Authors: Xiaoya Zhao | Species: mouse
  47. Iron overload-induced ferroptosis in CD8(+) T cells leads to functional abnormalities that promote endometriosis progression.
    Journal: BMC Med | Authors: Shuang Wang | Species: mouse,human | Application: IF
  48. Nonshrinkable Thermosensitive Hydrogels Combined with Bispecific Anti-PSMA/CD3 T-Cell Engager for Effective Against Tumors in Mice Model
    Journal: Int J Nanomedicine | Authors: Pu-Sheng Wei | Species: human | Application: IHC
  49. Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy.
    Journal: Cancer Immunol Res | Authors: Chunlin Li | Species: mouse | Application: IHC
  50. c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.
    Journal: Clin Transl Med | Authors: Lan Zhang | Species: mouse | Application: IHC
  51. METTL3/CD98-mediated glutamate efflux in CAFs drives CD8(+) T cell exhaustion and impedes neoadjuvant immunochemotherapy.
    Journal: Cell Rep | Authors: Chunyu Feng
  52. Picroside II promotes HSC apoptosis and inhibits the cholestatic liver fibrosis in Mdr2-/- mice by polarizing M1 macrophages and balancing immune responses
    Journal: Chin J Nat Med | Authors: Kexin Jia | Species: mouse | Application: WB
  53. Electroacupuncture enhances anti-tumor immunity in TNBC by reducing NE release and blocking α2-AR-mediated NGF/Hippo signaling.
    Journal: Chin Med | Authors: Fei-Fei Li
  54. EZH2 inhibitor enhances the STING agonist-induced antitumor immunity in melanoma.
    Journal: J Invest Dermatol | Authors: Tianxiao Xu | Species: human | Application: IHC
  55. Engineered NK92 cell-derived exosomes inhibit ovarian cancer progression by degrading GPRC5A.
    Journal: Front Immunol | Authors: Chaohua Si | Species: human | Application: WB
  56. EZH2 inhibitor enhances the STING agonist-induced antitumor immunity in melanoma.
    Journal: J Invest Dermatol | Authors: Tianxiao Xu | Species: human | Application: IHC
  57. Targeting PDPN enhances antitumor T-cell activity by disrupting β-catenin-mediated PD-L1 expression in melanoma.
    Journal: Front Immunol | Authors: Chunyan Feng | Species: mouse | Application: IF
  58. Mechanistic studies on the regulation of systemic sclerosis progression by imbalance in angiogenic T cell subsets.
    Journal: J Autoimmun | Authors: Haomiao Shen | Species: human | Application: WB
  59. Metabolic reprogramming in lacrimal gland GVHD: Stage-specific shifts in acinar cells as drivers of disease progression.
    Journal: Ocul Surf | Authors: Kaifeng Jin | Species: mouse | Application: IF
  60. Granzyme B is recovered by natural killer cells via clathrin-dependent endocytosis.
    Journal: Cell Mol Life Sci | Authors: Li Pan P | Species: human | Application: WB,IF
  61. Granzyme B is recovered by natural killer cells via clathrin-dependent endocytosis.
    Journal: Cell Mol Life Sci | Authors: Li Pan P | Species: human | Application: WB,IF
  62. Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy.
    Journal: Oncoimmunology | Authors: Qingyun Yuan | Species: mouse | Application: IF
  63. CD161+CD127+CD8+ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
    Journal: Oncoimmunology | Authors: Jingjing Qu | Species: human | Application: IF
  64. The peptide-based bispecific CAR T cells target EGFR and tumor stroma for effective cancer therapy
    Journal: Int J Pharm | Authors: Cuijuan Liu | Species: human | Application: IHC
  65. CD80-Mediated T-Cell Suppression by Cancer Stem-like Cells in Head and Neck Squamous Cell Carcinoma.
    Journal: Cells | Authors: Mian Xiao | Species: mouse | Application: IHC
  66. Nanocomposites integrating antigen release and presentation for treatment of sarcoma.
    Journal: Colloids Surf B Biointerfaces | Authors: Jincheng Wu | Species: mouse | Application: IHC
  67. SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2.
    Journal: Commun Biol | Authors: Yumeng Zhang | Species: human | Application: IF
  68. Systemic administration of STING agonist promotes myeloid cells maturation and antitumor immunity through regulating hematopoietic stem and progenitor cell fate
    Journal: Cancer Immunol Immunother | Authors: Tianxiao Xu | Species: mouse | Application: IHC
  69. Reforming the Chimeric Antigen Receptor by Peptide Towards Optimized CAR T Cells With Enhanced Anti-Cancer Potency and Safety.
    Journal: Front Bioeng Biotechnol | Authors: Cuijuan Liu | Species: human | Application: IHC
  70. KSR2 functions as a metabolic checkpoint for anti-PD-1 resistance by reprogramming glucose metabolism.
    Journal: Cancer Immunol Immunother | Authors: Yuli Ge | Species: mouse | Application: IF
  71. Luteolin Targets Peroxiredoxin 2 to Augment T-Cell-Mediated Cytotoxicity and Suppress Lung Adenocarcinoma Progression
    Journal: Eur J Pharmacol | Authors: Xuan Li | Species: mouse,human | Application: WB,IHC
  72. Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting PD-L1 expression.
    Journal: Int Immunopharmacol | Authors: Xiaomin Cai | Species: human | Application: IHC
  73. Exploring the effect of polyamines on NK cell function in colorectal cancer process based on glycolysis
    Journal: Int Immunopharmacol | Authors: Huan He | Species: mouse,human | Application: WB
  74. Antitumor effects of IOX1 combined with bevacizumab-induced apoptosis and immunity on colorectal cancer cells
    Journal: Int Immunopharmacol | Authors: Shuilong Fang | Species: mouse | Application: IHC
  75. Anti-Her2 CAR-NK92 Cells and Their Exosomes: Generation, Characterization, and Selective Cytotoxicity Against Her2-Positive Tumor Cells.
    Journal: Int J Mol Sci | Authors: Alexandru Tîrziu | Species: human | Application: WB
  76. The Role of Tim-3 on dNK Cells Dysfunction During Abnormal Pregnancy With Toxoplasma gondii Infection.
    Journal: Front Cell Infect Microbiol | Authors: Teng Li | Species: human | Application: WB,IF
  77. Next-generation probiotics Alistipes onderdonkii enhances the efficacy of anti-PD-1 therapy in colorectal cancer
    Journal: Biochim Biophys Acta Mol Basis Dis | Authors: Jiaxuan Xin | Species: mouse | Application: WB
  78. MEK inhibitor cobimetinib increases calreticulin and induces immune modulation in TNBC.
    Journal: J Mol Med (Berl) | Authors: Ling-Ming Tseng | Species: mouse | Application: IF
  79. The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms
    Journal: Sci Rep | Authors: Zhijiang Chen
  80. CD8+ T cells in Hashimoto's thyroiditis-associated papillary thyroid carcinoma.
    Journal: Eur Thyroid J | Authors: Lirong Wang | Species: human | Application: IF-P
  81. A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
    Journal: Clin Exp Med | Authors: Juan Zhang | Species: human | Application: IHC
  82. Ginsenoside Rb1 Maintains Tunneling Nanotubes between Astrocytes and Neurons To Protect Mice from Cerebral ischemia/reperfusion Injury.
    Journal: Neurochem Res | Authors: Wei Chen | Species: mouse | Application: WB
  83. ANLN promotes head and neck squamous cell carcinoma progression by upregulating PD-L1 via the ERK-MAPK pathway
    Journal: iScience | Authors: Lei Wang | Species: human | Application: IF
  84. A High-Affinity Anti-ITGB5 Nanobody for Hepatocellular Carcinoma: Antitumor Efficacy and Tumor Microenvironment Reprogramming.
    Journal: J Biol Chem | Authors: Wenzhang Wu
  85. Exploring the molecular mechanisms of the involvement of GZMB-Caspase-3-GSDME pathway in the progression of rheumatoid arthritis
    Journal: Mol Immunol | Authors: Yue Zhang | Species: rat,human | Application: WB
  86. VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway.
    Journal: Mol Immunol | Authors: Xiaoyin Wang | Species: human | Application: WB
  87. Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity
    Journal: Toxicol Appl Pharmacol | Authors: Anping Song | Species: human | Application: WB
  88. Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice.
    Journal: Toxicol Appl Pharmacol | Authors: Lingyan Xu | Species: mouse | Application: IHC
  89. Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD-L1 axis in gastric cancer
    Journal: Mol Carcinog | Authors: Qi Zhang | Species: mouse | Application: IHC
  90. Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer.
    Journal: Front Oncol | Authors: Jinguo Zhang | Species: human | Application: IHC
  91. The SIX1/LDHA Axis Promotes Lactate Accumulation and Leads to NK Cell Dysfunction in Pancreatic Cancer
    Journal: J Immunol Res | Authors: Wanli Ge | Species: human | Application: WB
  92. ETV4 enhances glycolysis to suppress NK-cell cytotoxicity in the immune microenvironment of colon cancer.
    Journal: Biochim Biophys Acta Gen Subj | Authors: Zixing Zhang
  93. Development and Validation of an Anoikis-Related Gene Signature for Prognostic Prediction in Cervical Cancer
    Journal: Int J Gen Med | Authors: Silu Meng | Application: IHC
  94. The development of anti-PD-1 antibody-induced spinal cord injury in bone marrow transplant C57BL/6 Rag1-/- mouse model
    Journal: Immunotherapy | Authors: Huachun Chen | Species: mouse | Application: WB
  95. Granzyme B as a potential biological target in toxic encephalopathy: A big data-based exploratory analysis
    Journal: Medicine (Baltimore) | Authors: Lijie Liu
  96. Identifying the Key Mitochondria-Related Genes in COPD by Integrating Machine Learning and Bioinformatics Analyses.
    Journal: Int J Genomics | Authors: Jiajia Qu | Species: mouse | Application: IF
  97. CTSG Suppresses Breast Cancer Progression by Inhibiting the EGFR/ERK Signaling Pathway and Enhancing CD8⁺ T Cell Activation.
    Journal: Clin Breast Cancer | Authors: Yue Pan
  98. Bifidobacterium animalis subsp. lactis V9 overcomes CYFRA 21-1-linked immunochemotherapy resistance in NSCLC via microbial metabolites.
    Journal: Sci Adv | Authors: Cuijiao Feng
  99. HSPA1A promotes immune-evasive colorectal liver metastasis through post-transcriptional stabilization of APP mRNA.
    Journal: Int Immunopharmacol | Authors: Ying Wan

Reviews

Write Your Own Review
You're reviewing:Granzyme B Polyclonal antibody 13588-1-AP proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.